My Cart [ 0 ]
New Products
New Services
News
Promotions
Home > Search Results
    16 products and services containing "il17a"
    Please click il17a to try advanced search.
  • PA007541.m1: In Vivo Grade Recombinant Anti-mouse TCR gamma/delta Monoclonal Antibody (Clone:  UC7-13D5), Mouse IgG1 Kappa

    Recombinant mouse IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: UC7-13D5) specifically binds to mouse TCR gamma/delta.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse TCR gamma/delta protein.

     

    PA007541.hs: In Vivo Grade Recombinant Anti-mouse TCR gamma/delta Monoclonal Antibody (Clone:  UC7-13D5), Armenian Hamster IgG Kappa

    Recombinant Hamster IgG Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade recombinant hamster monoclonal antibody (clone: UC7-13D5) specifically binds to mouse TCR gamma/delta.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse TCR gamma/delta protein.

     

  • C038P: Ustekinumab Biosimilar, IL-12 / IL-23 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade ustekinumab biosimilar specifically binds to the human interleukin-12 (IL-12) and interleukin-23 (IL-23).
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ustekinumab.

  • C041P: Briakinumab Biosimilar, IL-12 / IL-23 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade briakinumab biosimilar specifically binds to the human interleukin-12 (IL-12) and interleukin-23 (IL-23).
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by briakinumab.

  • C032P: Tocilizumab Biosimilar, Anti-Human IL-6R Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade tocilizumab biosimilar specifically binds to the human interleukin-6 receptor (IL-6R).
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tocilizumab.

  • BP005192: Biotinylated Mouse IL-17A/CTLA-8 Protein with the C-His-Avi Tag

    Source: The recombinant Biotinylated Mouse IL-17A/CTLA-8 Protein, (amino acids Ala26-Ala158) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
    Activity: Immobilized recombinant Mouse IL-17R alpha protein with the C-His-Avi tag at 2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Mouse IL-17A protein with the C-His tag with the EC50 of 28.3 ng/ml determined by ELISA.
    Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
    Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

  • BP000140-C021: Recombinant Human Interleukin-17A (IL-17A) Protein

    Source: E. coli-derived.
    The ED50 as determined by the dose-dependent induction of IL-6 in primary human foreskin fibroblasts was found to be approximately 2 ug/ml, corresponding to a Specific Activity of 5 x 105 IU/mg.
    Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
    Endotoxin: < 0.1 ng/ug (1 IEU/ug).

  • BP000139-CYT-623: Recombinant Human IL-17 A/F Heterodimer

    Source: E. coli-derived.
    Purity > 98%, by SDS-PAGE.

  • BP000139-CYT-640: Recombinant Mouse IL-17 A/F Heterodimer

    Source: E. coli-derived.
    Purity > 97%, by SDS-PAGE.

  • BP000139-CYT-677: Recombinant Rat IL-17 A/F Heterodimer

    Source: E. coli-derived.
    Purity > 97%, by SDS-PAGE.

  • BP000140-CYT-102: Recombinant Human Interleukin-17A (IL-17A), HEK Protein

    Source: HEK-derived.
    The specific activity was determined by the dose-dependent induction of IL-6 secretion from NDHF Adult fibroblasts and is typically 5-25 ug/ml.
    Purity: > 95% as obsereved by SDS-PAGE.

See our Privacy Policy